The solution structure of the domain from MeCP2 that binds to methylated DNA - PubMed (original) (raw)
. 1999 Sep 3;291(5):1055-65.
doi: 10.1006/jmbi.1999.3023.
Affiliations
- PMID: 10518942
- DOI: 10.1006/jmbi.1999.3023
The solution structure of the domain from MeCP2 that binds to methylated DNA
R I Wakefield et al. J Mol Biol. 1999.
Abstract
MeCP2 is an abundant mammalian protein that binds methylated CpG (mCpG) sequences within double-stranded DNA, represses transcription by recruiting histone deacetylases, and is essential for embryonic development. It is one of a family of proteins which mediate the biological consequences of DNA methylation. These proteins each possess a sequence motif of about 70 residues which, in MeCP2, form a domain necessary and sufficient for binding to mCpG. The solution structure of the mCpG-binding domain (MBD) from MeCP2 has been solved and the DNA-binding surface of the domain mapped using NMR spectroscopy. Residues 95-162 of MeCP2 adopt a novel fold forming a wedge-shaped structure. An N-terminal four-stranded antiparallel beta-sheet forms one face of the wedge, while the other face is formed mainly by a C-terminal helical region. The thin end of the wedge is extended by a long loop between beta-strands B and C containing many basic residues. The B-C loop together with residues in strands B, C and D, and at the N terminus of the alpha-helix, appears to form an interface with methylated DNA. Unstructured residues at the NH2 terminus of the domain are also involved in formation of the complex. The presence of numerous arginine and lysine side-chains on the DNA-binding surface of MBD is consistent with the requirement for the mCpG site to be flanked by non-specific sequences of base-pairs. The absence of symmetry in the domain implies that recognition does not exploit the symmetry of the binding site. A conserved hydrophobic pocket containing the side-chains of Tyr123 and Ile125 on the positively charged beta-sheet face is a candidate for the region of contact with the methyl-groups of the modified cytosine residues.
Similar articles
- Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.
Ohki I, Shimotake N, Fujita N, Nakao M, Shirakawa M. Ohki I, et al. EMBO J. 1999 Dec 1;18(23):6653-61. doi: 10.1093/emboj/18.23.6653. EMBO J. 1999. PMID: 10581239 Free PMC article. - NMR solution structure of the archaebacterial chromosomal protein MC1 reveals a new protein fold.
Paquet F, Culard F, Barbault F, Maurizot JC, Lancelot G. Paquet F, et al. Biochemistry. 2004 Nov 30;43(47):14971-8. doi: 10.1021/bi048382z. Biochemistry. 2004. PMID: 15554704 - Solution structure of the DNA-binding domain of NtrC with three alanine substitutions.
Pelton JG, Kustu S, Wemmer DE. Pelton JG, et al. J Mol Biol. 1999 Oct 8;292(5):1095-110. doi: 10.1006/jmbi.1999.3140. J Mol Biol. 1999. PMID: 10512705 - Methyl CpG-binding proteins and transcriptional repression.
Wade PA. Wade PA. Bioessays. 2001 Dec;23(12):1131-7. doi: 10.1002/bies.10008. Bioessays. 2001. PMID: 11746232 Review. - MeCP2 and other methyl-CpG binding proteins.
Jørgensen HF, Bird A. Jørgensen HF, et al. Ment Retard Dev Disabil Res Rev. 2002;8(2):87-93. doi: 10.1002/mrdd.10021. Ment Retard Dev Disabil Res Rev. 2002. PMID: 12112733 Review.
Cited by
- MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities.
Beribisky AV, Huber A, Sarne V, Spittler A, Sukhbaatar N, Seipel T, Laccone F, Steinkellner H. Beribisky AV, et al. Protein Sci. 2024 Oct;33(10):e5170. doi: 10.1002/pro.5170. Protein Sci. 2024. PMID: 39276009 Free PMC article. - Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials.
Lopes AG, Loganathan SK, Caliaperumal J. Lopes AG, et al. Brain Sci. 2024 Jan 24;14(2):120. doi: 10.3390/brainsci14020120. Brain Sci. 2024. PMID: 38391695 Free PMC article. Review. - Methylated Nucleotide-Based Proteolysis-Targeting Chimera Enables Targeted Degradation of Methyl-CpG-Binding Protein 2.
Wang Z, Liu J, Qiu X, Zhang D, Inuzuka H, Chen L, Chen H, Xie L, Kaniskan HÜ, Chen X, Jin J, Wei W. Wang Z, et al. J Am Chem Soc. 2023 Oct 11;145(40):21871-21878. doi: 10.1021/jacs.3c06023. Epub 2023 Sep 29. J Am Chem Soc. 2023. PMID: 37774414 Free PMC article. - Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage.
Collins BE, Neul JL. Collins BE, et al. Neuropsychiatr Dis Treat. 2022 Nov 29;18:2813-2835. doi: 10.2147/NDT.S371483. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36471747 Free PMC article. Review. - Expression, Purification, Characterization and Cellular Uptake of MeCP2 Variants.
Beribisky AV, Steinkellner H, Geislberger S, Huber A, Sarne V, Christodoulou J, Laccone F. Beribisky AV, et al. Protein J. 2022 Apr;41(2):345-359. doi: 10.1007/s10930-022-10054-9. Epub 2022 May 12. Protein J. 2022. PMID: 35546650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases